BioMimetic Therapeutics (BMTI)
BioMimetic Therapeutics Income Statement
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Income | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Revenue | 0.4664M | 0.4584M | 0.4286M | 0.4393M | 0.3987M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cost of Revenue | 0.0155M | 0.0192M | 0.0124M | 0.0091M | 0.0127M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Gross Profit | 0.4509M | 0.4391M | 0.4163M | 0.4301M | 0.386M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Research & Development Expense | 2.768M | 3.242M | 3.605M | 3.763M | 4.085M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Selling, General, & Admin. Expense | 3.448M | 3.773M | 3.586M | 4.653M | 4.022M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation & Amortization | 0.3754M | 0.3721M | 0.3693M | 0.2797M | 0.2723M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Operating Interest Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Operating Income (Expense) | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Operating Expenses | 6.606M | 7.406M | 7.572M | 8.705M | 8.392M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Operating Income | -6.140M | -6.948M | -7.144M | -8.266M | -7.993M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Non-Operating Income | 0.0229M | -2.926M | 0.0211M | 0.0249M | 0.0401M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Pretax Income | -6.117M | -9.873M | -7.122M | -8.241M | -7.953M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Provision for Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Income after Tax | -6.117M | -9.873M | -7.122M | -8.241M | -7.953M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Equity In Affiliates | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income Before Extraordinaries & Disc. Operations | -6.117M | -9.873M | -7.122M | -8.241M | -7.953M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Investment Gains/Losses | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Income/Charges | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income from Discontinued Operations | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Income | -6.117M | -9.873M | -7.122M | -8.241M | -7.953M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Earnings Per Share Data | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Average Shares to compute diluted EPS | 28.15 | 28.00 | 28.04 | 27.98 | 27.93 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Average Shares used to compute basic EPS | 28.15 | 28.00 | 28.04 | 27.98 | 27.93 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS - Basic net | -0.22 | -0.37 | -0.25 | -0.29 | -0.28 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS - Diluted net | -0.22 | -0.37 | -0.25 | -0.29 | -0.28 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
